Director Shareholding

Deltex Medical Group PLC 07 May 2003 Deltex Medical Group plc ('Deltex Medical' or the 'Company') Director Shareholdings Deltex Medical announced yesterday that it has completed its fundraising of approximately £1.32 million before expenses, involving the subscription of 18,858,499 new ordinary shares at 7p per share by various institutional and other investors and the Directors. As previously announced on 1 April 2003, in order to demonstrate their confidence in the Group's prospects, the Directors have participated as investors in the fundraising, subscribing approximately £0.36 million. Their interests in the Company's total issued ordinary share capital following completion of the fundraising are as follows: Following the fundraising Name of Director Amount Number of Holding of % of issued subscribed subscription shares share capital shares £ Nigel Keen 150,000 2,142,857 2,862,544 5.10 Nigel Keen (1) - - 589,700 1.05 Andy Hill 3,000 42,857 42,857 0.08 Ewan Phillips 20,000 285,714 365,714 0.65 Daniel Bretonneau 10,000 142,857 142,857 0.25 Edwin Snape (2) 160,000 2,285,714 2,879,925 5.13 Kempton Coady 1,260 18,000 58,000 0.10 George Flouty 4,500 64,285 134,285 0.24 Peter Smedvig (3) 13,020 186,000 664,478 1.18 ------------ ------------ ------------ ------------ 361,780 5,168,284 7,740,360 13.78 ------------ ------------ ------------ ------------ (1) as trustee and executor of the Pauline Thomas Charity Will Trust (2) as principal of NEGF II L.P. and New England Partners Capital L.P. (3) as director of Peder Smedvig Capital AS 7 May 2003 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings